Evidence map›Paper›PMID 33396587›Full record

ArticleDiagnostics (Basel, Switzerland)2020

Development and Validation of an Automated Radiomic CT Signature for Detecting COVID-19.

Julien Guiot, Akshayaa Vaidyanathan, Louis Deprez, Fadila Zerka, Denis Danthine, Anne-Noëlle Frix, Marie Thys, Monique Henket, Gregory Canivet, Stephane Mathieu and 11 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04750330 (Mitochondrial DNA and Nuclear SNPs to Predict Severity of COVID-19 Infection), which is not on this map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04750330 completednot on this mapstarted 2021, after this paper: background citation

Mitochondrial DNA and Nuclear SNPs to Predict Severity of COVID-19 Infection

TypeobservationalSponsorMaastricht UniversityRan2021 to 2023Enrolled394ConditionsCovid19
3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 49 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 2 institutions in 2 countries.

Julien GuiotDepartment of Pneumology, University Hospital of Liège, 4020 Liège, Belgium.ORCID 0000-0001-7800-1730
Akshayaa VaidyanathanResearch and Development, Oncoradiomics SA, 4000 Liège, Belgium.ORCID 0000-0001-8012-6516
Louis DeprezDepartment of Radiology, University Hospital of Liège, 4020 Liège, Belgium.
Fadila ZerkaResearch and Development, Oncoradiomics SA, 4000 Liège, Belgium.
Denis DanthineDepartment of Radiology, University Hospital of Liège, 4020 Liège, Belgium.
Anne-Noëlle FrixDepartment of Pneumology, University Hospital of Liège, 4020 Liège, Belgium.
Marie ThysDepartment of Medico-Economic Information, University Hospital of Liège, 4020 Liège, Belgium.
Monique HenketDepartment of Pneumology, University Hospital of Liège, 4020 Liège, Belgium.
Gregory CanivetDepartment of Computer Applications, University Hospital of Liège, 4020 Liège, Belgium.
Stephane MathieuDepartment of Computer Applications, University Hospital of Liège, 4020 Liège, Belgium.
Evanthia EftaxiaDepartment of Radiology, University Hospital of Liège, 4020 Liège, Belgium.
Philippe LambinThe D-Lab, Department of Precision Medicine, Maastricht University, 6229 Maastricht, The Netherlands.ORCID 0000-0001-7961-0191
Nathan TsoutzidisResearch and Development, Oncoradiomics SA, 4000 Liège, Belgium.
Benjamin MiraglioResearch and Development, Oncoradiomics SA, 4000 Liège, Belgium.
Sean WalshResearch and Development, Oncoradiomics SA, 4000 Liège, Belgium.
Michel MoutschenDepartment of Infectious Diseases, University Hospital of Liège, 4020 Liège, Belgium.
Renaud LouisDepartment of Pneumology, University Hospital of Liège, 4020 Liège, Belgium.
Paul MeunierDepartment of Radiology, University Hospital of Liège, 4020 Liège, Belgium.
Wim VosResearch and Development, Oncoradiomics SA, 4000 Liège, Belgium.ORCID 0000-0003-0827-421X
Ralph T H LeijenaarResearch and Development, Oncoradiomics SA, 4000 Liège, Belgium.
Pierre LovinfosseDepartment of Nuclear Medicine and Oncological Imaging, University Hospital of Liège, 4020 Liège, Belgium.
University of Liège · BEMaastricht University · NL

Funding

European Research Council ERC-ADG-2015, n° 694812 -  HypoximmunoFP7 People: Marie-Curie Actions PREDICT - ITN - n° 766276Stichting Euregio Maas-Rijn EMR4
6 · The paper itself

Abstract

The coronavirus disease 2019 (COVID-19) outbreak has reached pandemic status. Drastic measures of social distancing are enforced in society and healthcare systems are being pushed to and beyond their limits. To help in the fight against this threat on human health, a fully automated AI framework was developed to extract radiomics features from volumetric chest computed tomography (CT) exams. The detection model was developed on a dataset of 1381 patients (181 COVID-19 patients plus 1200 non COVID control patients). A second, independent dataset of 197 RT-PCR confirmed COVID-19 patients and 500 control patients was used to assess the performance of the model. Diagnostic performance was assessed by the area under the receiver operating characteristic curve (AUC). The model had an AUC of 0.882 (95% CI: 0.851-0.913) in the independent test dataset (641 patients). The optimal decision threshold, considering the cost of false negatives twice as high as the cost of false positives, resulted in an accuracy of 85.18%, a sensitivity of 69.52%, a specificity of 91.63%, a negative predictive value (NPV) of 94.46% and a positive predictive value (PPV) of 59.44%. Benchmarked against RT-PCR confirmed cases of COVID-19, our AI framework can accurately differentiate COVID-19 from routine clinical conditions in a fully automated fashion. Thus, providing rapid accurate diagnosis in patients suspected of COVID-19 infection, facilitating the timely implementation of isolation procedures and early intervention.

Indexed as

artificial intelligencecomputed tomographyCOVID-19machine learningradiomics

Identifiers

PMID33396587
PMCPMC7823620
OpenAlexW3117732482

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.